Why proteomics?
SAME GENOTYPE. DIFFERENT PHENOTYPE.
PROTEIN ASSAYS COMPLEMENT GENOMICS TO IDENTIFY:
- Patient subpopulations
- Novel therapeutic targets
- New disease applications for approved drugs
- Possible safety concerns
- Mechanisms of action
Measure What Matters Most
Proteins signify health.
The ~30,000 proteins that make up the human proteome orchestrate the majority of biological processes. By measuring proteins, we can identify patterns of wellness, fitness, and aging.
Proteins reflect treatment.
Medications and lifestyle changes cause shifts in the proteome. By measuring proteins, we can determine if treatments are working.
Proteins reveal risk.
Adverse reactions to drugs, health complications, and comorbidities are also determined by proteins. By measuring proteins, we can identify good candidates for clinical trials.
Proteins are dynamic.
Unlike the genome, which is relatively fixed over time, proteins provide a snapshot of health in real time.
Proteins are accessible.
Key proteins circulate in blood and other fluids, making them easy to sample.
Proteins are the future.
In the past, we’ve looked to the genome, because measuring proteins was too technically challenging. With our pioneering platform, we can now measure 7,000 proteins across a 10-log fold range of concentrations from a single sample.
